MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 11, 2008; DOI: 10.1124/mol.108.045963


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.045963v1
73/6/1776    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Franck Madoux
Xiaolin Li
Peter Chase
Gina Zastrow
Michael D. Cameron
Juliana J. Conkright
Patrick R. Griffin
Scott Thacher
Peter Hodder
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Madoux, F.
Right arrow Articles by Hodder, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madoux, F.
Right arrow Articles by Hodder, P.


Received for publication February 5, 2008.
Revised March 7, 2008.
Accepted for publication March 10, 2008.

Potent, selective and cell penetrant inhibitors of SF-1 by functional uHTS

Franck Madoux 1, Xiaolin Li 2, Peter Chase 1, Gina Zastrow 1, Michael D. Cameron 1, Juliana J. Conkright 1, Patrick R. Griffin 1, Scott Thacher 2, Peter Hodder 1*

1 The Scripps Research Institute 2 Orphagen Pharmaceuticals

* Address correspondence to: E-mail: hodderp{at}scripps.edu

Abstract

The Steroidogenic factor 1 (SF-1, also known as NR5A1) is a transcription factor belonging to the nuclear receptor superfamily. Whereas most of the members of this family have been extensively characterized, the therapeutic potential and pharmacology of SF-1 still remains elusive. Described here is the identification and characterization of selective inhibitory chemical probes of SF-1 by a rational ultra-high-throughput screening (uHTS) strategy. A set of 64,908 compounds from the National Institute of Health's Molecular Libraries Small Molecule Repository (MLSMR) was screened in a transactivation cell-based assay employing a chimeric SF-1 construct. Two analogous isoquinolinones, SID7969543 and SID7970631, were identified as potent submicromolar inhibitors, yielding IC50 values of 760 nM and 260 nM. The compounds retained their potency in a more physiologic functional assay employing the full-length SF-1 protein and its native response element, yielding IC50 values of 30 and 16 nM, respectively. The selectivity of these isoquinolinones was confirmed via transactivation-based functional assays for RORA, VP-16 and LRH-1. Their cytotoxicity, solubility, permeability and metabolic stability were also measured. These isoquinolinones represent valuable chemical probes to investigate the therapeutic potential of SF-1.


Key words: Sex hormones, Transcriptional coactivators, Mutagenesis/Chimeric approaches, Transcription targets, Endocrine cells





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics